RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU)

Clinical trial NCT05154344 · COMPLETED

Trial details

NCT number: NCT05154344
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Status: COMPLETED
Study type: OBSERVATIONAL

MET Alterations Non Small Cell Lung Cancer METex14 Mutations

Start date: 2021-11-29
Primary completion: 2022-02-01
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.